Navigation Links
Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Date:8/19/2007

WEST BRIDGEWATER, Mass., Aug. 14 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced that total revenue for the quarter ended June 30, 2007 was $202,127 as compared to $28,783 for the same period in 2006. Revenue from the sale of PCT products and services was $136,355 for the three months ended June 30, 2007 as compared to $28,783 for the same period in the prior year. This increase in revenue from PCT products and services was the result of the sale of four Barocycler NEP3229 PCT Sample Preparation Systems in the second quarter of 2007 versus one in the second quarter of 2006. Also contributing to this increase in revenue was an increase in the number of PULSE Tubes that were sold, revenue from Barocycler NEP3229 instruments under lease, and the recognition of extended service contract revenue. In addition to revenue received from the sale of PCT products and services, the Company also recorded $65,772 of grant revenue during the second quarter of 2007. The majority of this revenue was billed pursuant to the Company's SBIR Phase 1 grant for the development of novel protein extraction methods based on the Company's patented pressure cycling technology (PCT). During the same period in 2006, the Company did not record any grant revenue.

The Company reported total revenue of $333,748 for the six months ended June 30, 2007 as compared to $82,197 for the six months ended June 30, 2006. Revenue from the sale of PCT products and services was $174,297 for the six months ended June 30, 2007 as compared to $82,197 for the same period in the prior year. This increase in revenue from PCT products and services was primarily the result of the sale of five Barocycler NEP3229 PCT Sample Preparati
'/>"/>

SOURCE Pressure BioSciences, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. The Analysis of Polycyclic Aromatic Hydrocarbons (PAHs) by LC/MS/MS Using an Atmospheric Pressure Photoionization Source
2. Determination of N-nitrosamines in Baby Bottle Rubber Teats by Liquid Chromatography-Atmospheric Pressure Chemical Ionization Mass Spectrometry
3. Screening of Corticosteroids in Urine by Negative Atmospheric Pressure Chemical Ionization LC/MS/MS
4. Medical College receives $11 million grant to study high blood pressure
5. Pressure mounts for Doyle to repeal shareholder liability law
6. Probe into gas gouging may educate Americans about pressures on oil supply
7. SWIB gets more pressure to invest in state tech start-ups
8. Technology puts pressure on old education methods
9. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
10. Sonic Foundry reports GAAP loss as Q2 revenues rise
11. Fiserv reports $113.5 million in Q1 profit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...an think of it as origami very high-tech origami.... developed a technique for fabricating three-dimen... thin films by coupling photolithography and a sel.... , The films, only a few microns thick, offer me...cker pieces of the same material. , "This is a co...
(Date:11/23/2009)...ov.23/PRNewswire-FirstCall/-YMBioSciencesInc.(NYSE...companythatidentifiesandadvancesadiverseportfolioo...evelopment,todayreportedthatCytopia(ASX:CYT)hascom...apotent,orally-administeredJAK1/JAK2inhibitor.Thet...ota.AproposaltomergeCytopiaintoYMhasbeenpreviously...
(Date:11/23/2009)...3/PRNewswire/-InimexPharmaceuticals,Inc.announcedt...sidentandCEO. ,, Abramsbringsmorethan25yearsofd...co-inventorofthenuclearmedicineimagingagent,Cardio...erehewasManager,BiomedicalResearchWorldwide.In1996...wasPresidentandCEOfrom1996to2006.AnorMEDdiscovered...
(Date:11/20/2009)..., , , , , , , ,...O: , A team of scientists from Washington Uni...old Spring Harbor Laboratory and Iowa State Univer..... , , Click here for more inform... , , , , , , , ...
Breaking Biology Technology:Water droplets direct self-assembly process in thin-film materials 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Inimex Announces Appointment of New CEO 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4
...arter Highlights:, -- Record revenues of $82.0 mi... quarter -- Non-re...n-GAAP earnings per share of $0.23, a 130% increas...arnings per share, -- Operating cash flow of $24.3...nch of four new food and beverage products and one...
...nnounces second office in Mumbai, WILMINGTON, N.C...ed the appointment of Philip Mathew, M.D., as dire...,s Phase II-IV operations and,expansion in India.,... PPD,s drug development,business on the Indian sub...nd patient recruitment for key therapeutic areas. ...
..., Calif., Dec. 12 Beckman Coulter,Inc. (NYSE: BE... and,automate complex biomedical testing, announce...officer, president, and director of AMN,Healthcare...the board of,directors of Beckman Coulter, effecti...gi-bin/prnh/20031202/BECLOGO ), "Susan is a high...
Other Biology Technology:Martek Announces Fourth Quarter and FY 2007 Financial Results 2Martek Announces Fourth Quarter and FY 2007 Financial Results 3Martek Announces Fourth Quarter and FY 2007 Financial Results 4Martek Announces Fourth Quarter and FY 2007 Financial Results 5Martek Announces Fourth Quarter and FY 2007 Financial Results 6Martek Announces Fourth Quarter and FY 2007 Financial Results 7Martek Announces Fourth Quarter and FY 2007 Financial Results 8Martek Announces Fourth Quarter and FY 2007 Financial Results 9Martek Announces Fourth Quarter and FY 2007 Financial Results 10Martek Announces Fourth Quarter and FY 2007 Financial Results 11Martek Announces Fourth Quarter and FY 2007 Financial Results 12Martek Announces Fourth Quarter and FY 2007 Financial Results 13Martek Announces Fourth Quarter and FY 2007 Financial Results 14Martek Announces Fourth Quarter and FY 2007 Financial Results 15Mathew to Lead PPD Drug Development Operations and Expansion in India 2Mathew to Lead PPD Drug Development Operations and Expansion in India 3Beckman Coulter Elects AMN Healthcare Executive to Board of Directors 2
(Date:11/24/2009)... Cambridge, Md. (November 24, 2009) New research ...ic river ecosystems reveals predictable temporal p...e communities as markers for monitoring climate ch...is week in the Proceedings of the National Academ... communities in the six rivers shifted synchronous...
(Date:11/23/2009)..., TORONTO, November 23, 2009 - The time of day ma...ing to a new paper produced by a research team led...nto Scarborough,s vice-principal for research and ...iology at the St. George campus. , Capitalizin...he poplar tree, the research team examined how pop...
(Date:11/23/2009)..., AMES, Iowa - The only swine vaccine available f...ne herd infected with the virus. The vaccination m...ne herd diagnosed with the pandemic flu., Iowa S... science, developed the vaccine this summer and ha...s in Iowa, Kansas and Illinois for several weeks.,...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Time of day matters to thirsty trees, U of T researcher discovers 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Doctors Stand Together Against Government Takeover of Healthcare on Sept 10th in DC 56566 1Simbionix USA Corporation Announces the Appointment of Mr Paul Jensen as General Manager for its Growing eLearning and Content Business 13943 1Simbionix USA Corporation Announces the Appointment of Mr Paul Jensen as General Manager for its Growing eLearning and Content Business 13943 2Champions Biotechnology to Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 13941 1Champions Biotechnology to Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 13941 2Champions Biotechnology to Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 13941 3
...er therapies often succeed at initially eliminatin...roliferating cells, but are eventually thwarted be...ultiple-drug-resistant tumor cells, called cancer ...disease recurrence and eventual metastasis. Now, r...rgh School of Medicine suggests that for chemother...
...e of human and animal infections, Staphylococcus a...ces and dodge antibiotics by climbing into our cel...arch in the online open access journal BMC Genomic...n lung cells for up to two weeks. , A team of 12 r...tzerland and the Institute of Food Research, Norwi...
...are drinking too much water, including sports drin...e individuals engaging in prolonged types of endur...intoxication, say international experts who study ...des marathons, triathlons, and long distance cycli...duced hyponatremia (EAH), could be prevented if on...
Other Biology News:Cancer stem cells similar to normal stem cells can thwart anti-cancer agents 2Staphylococcus aureus hides out in cells 2Runners -- Let thirst be your guide 2Runners -- Let thirst be your guide 3Runners -- Let thirst be your guide 4
...t not structural information the AXIMA-LNR linear ...high throughput QA/QC applications and for high pe...lude oligonucleotide QA/QC, SNP analysis, protein ...d polymer analysis, with the ability to run up to ...
RAOEC (R304-05) from European Collection of Cell Cultures (ECACC)
...modular instrument which can be used for a variety...lar, Transducer & Multi-channel Isolated Amplifica...L900D) forms the heart of every NeuroLog System. ...ing within the case allows signals to be passed be...
Mouse Anti-Drosophila Yan Drosophila protein Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Biology Products: